<?xml version="1.0" encoding="UTF-8"?>
<ref id="B102">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Qu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Easson</surname>
    <given-names>M. L. A. E.</given-names>
   </name>
   <name>
    <surname>Froese</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Simionescu</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Hudlicky</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>DeLuca</surname>
    <given-names>V.</given-names>
   </name>
  </person-group> (
  <year>2015</year>). 
  <article-title>Completion of the seven-step pathway from tabersonine to the anticancer drug precursor vindoline and its assembly in yeast.</article-title>
  <source>
   <italic>Proc. Natl. Acad. Sci. U. S. A.</italic>
  </source>
  <volume>112</volume>
  <fpage>6224</fpage>â€“
  <lpage>6229</lpage>. 
  <pub-id pub-id-type="doi">10.1073/pnas.1501821112</pub-id>
  <?supplied-pmid 25918424?>
  <pub-id pub-id-type="pmid">25918424</pub-id>
 </mixed-citation>
</ref>
